Atlas Trials

MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma

Clinical trial NCT07054307 · RECRUITING

Trial details

NCT number
NCT07054307
Sponsor
Jiyan Liu
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Penile Cancer
Start date
2026-02-12
Primary completion
2026-07-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.